The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/foc.4.1.48

Objective: The authors examined racial/ethnic variations in psychiatric diagnoses and clinical characteristics of psychiatric patients as assessed and reported by psychiatrists in routine clinical practice. Method: A national sample of psychiatrists provided detailed clinical data on 2,561 adult patients they treated in their routine practice settings. African American (n=254) and Hispanic patients (n=149) were compared with non-Hispanic white patients (n=2,158). Logistic regression analysis was used to assess racial/ethnic differences in diagnosis after adjustment for sociodemographic and care setting/payment characteristics. Results: African American patients were more likely to receive a diagnosis of a schizophrenia spectrum disorder or a nonalcohol substance use disorder and less likely to receive a diagnosis of a depressive or anxiety disorder, compared with white patients. After adjusting for sociodemographic and care setting/payment factors, differences in rates of schizophrenia spectrum disorders were no longer statistically significant; African Americans also remained more likely to be diagnosed as having a nonalcohol substance use disorder (odds ratio=1.8, 95% CI=1.09–3.03); and African American men remained less likely than white men to be diagnosed as having bipolar disorder (odds ratio=0.26, 95% CI=0.09–0.80) or anxiety disorders (odds ratio=0.35, 95% CI=0.14–0.85). No differences in adjusted rates of schizophrenia, depression, bipolar, or anxiety disorders were observed for Hispanic patients compared with white patients. Conclusions: Psychometric validation of patients’ diagnoses and current symptoms is needed to understand the extent to which these observed racial/ethnic differences in diagnoses may reflect differential patterns of detection in routine psychiatric practice.